TrialChinese medical journal2016

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients.

Hang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.